Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > VMS+4.0, to Health Canada for approval! 🎉
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 13, 2024 10:13am
108 Views
Post# 36176401

RE:VMS+4.0, to Health Canada for approval! 🎉

RE:VMS+4.0, to Health Canada for approval! 🎉I think of exciting moments. FDA V4.0 and Sales at any time now Insiders know!Post Bart Hendriks I'm excited to share that Ventripoint has just submitted its latest AI-powered heart-scanning technology, VMS+4.0, to Health Canada for approval! This new version is designed to seamlessly integrate into clinical workflows.

and  Always confident for GEHC, as for China! Interesting (VMS+2.0 is being manufactured and used in leading hospitals in China through a partnership). those thought this partnership was dead! For Brazil? The elephant? I think Dr. Adams the visionary with Ventripoint will surprise us again with the upcoming FDA V4.0
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities